Summaries for Patients |

High Homocysteine Levels Increase Risk for Heart Attacks in People with Type 2 Diabetes Mellitus FREE

[+] Article, Author, and Disclosure Information

The summary below is from the full report titled “Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes Mellitus.” It is in the 20 January 2004 issue of Annals of Internal Medicine (volume 140, pages 94-100). The authors are M. Soinio, J. Marniemi, M. Laakso, S. Lehto, and T. Rönnemaa.

Ann Intern Med. 2004;140(2):I-31. doi:10.7326/0003-4819-140-2-200401200-00003
Text Size: A A A

What is the problem and what is known about it so far?

Heart attacks remain leading causes of death and disability in most western countries. Smoking, high-fat diet, high cholesterol level, high blood pressure, diabetes, and kidney disease increase a person's risk for coronary heart disease and heart attacks. Recently, researchers identified several additional risk factors for heart disease. One of them is homocysteine level. Homocysteine is an amino acid that may be increased when intake of vitamins, such as folic acid, is low. Most studies that show that high homocysteine levels increase risk for heart attacks were in patients who already had coronary artery disease and did not have diabetes. Few studies address whether homocysteine level increases risks for heart attacks in people with diabetes mellitus.

Why did the researchers do this particular study?

To see whether high levels of homocysteine increase risks for heart attacks in adults with type 2 diabetes.

Who was studied?

830 Finnish men and women, 45 to 64 years of age, with type 2 diabetes.

How was the study done?

Researchers identified adults with diabetes from a Finnish national drug registry. Between 1982 and 1984, they measured each person's blood pressure and weight. They asked about smoking habits, alcohol intake, physical activity, medications, and chest pain. They took blood tests to measure levels of homocysteine, glucose, cholesterol and other lipids, and creatinine (a measure of kidney function). They also used blood tests (C-peptide values) to see which patients had type 1 and type 2 diabetes. Seven years later, the researchers reviewed death certificates and medical records to see whether anyone had died of or had been hospitalized with a heart attack. They then examined whether the heart attacks occurred more often in persons who had high homocysteine levels 7 years previously.

What did the researchers find?

High levels of homocysteine (plasma homocysteine levels ≥ 15 µmol/L) were associated with increased risk for fatal and nonfatal heart attacks, even after accounting for several other risk factors. High homocysteine levels also increased risks for death from heart attack.

What were the limitations of the study?

Researchers used a drug registry to identify study participants. Healthier people with early and less severe type 2 diabetes might not be listed in the registry. The study did not measure folate intake or changes in risk factors over time. It cannot tell us whether lowering homocysteine level with higher folate intake would reduce coronary artery disease.

What are the implications of the study?

Homocysteine is an independent risk factor for heart attacks in adults with type 2 diabetes.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.